P930021S024

None

FDA Premarket Approval P930021 S024

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

• Device: P930021S024
• Classification Name: None
• PMA: P930021
• Supplement: S024

Supplemental Filings

Supplement Number	Date	Supplement Type
P930021		Original Filing
S030	2023-01-04	30-day Notice
S029	2022-10-17	30-day Notice
S028
S027	2021-01-29	30-day Notice
S026	2020-08-12	30-day Notice
S025	2019-08-09	30-day Notice
S024
S023	2018-11-02	135 Review Track For 30-day Notice
S022	2018-10-24	135 Review Track For 30-day Notice
S021	2018-10-22	135 Review Track For 30-day Notice
S020	2018-05-10	30-day Notice
S019	2018-04-13	135 Review Track For 30-day Notice
S018	2017-12-15	135 Review Track For 30-day Notice
S017	2016-09-09	135 Review Track For 30-day Notice
S016	2016-04-06	Normal 180 Day Track
S015	2015-06-29	30-day Notice
S014	2015-03-02	Normal 180 Day Track
S013	2012-09-19	Normal 180 Day Track No User Fee
S012	2009-01-12	Normal 180 Day Track No User Fee
S011	2008-03-27	Normal 180 Day Track
S010	2007-10-09	Real-time Process
S009	2006-04-11	Special (immediate Track)
S008	2002-09-13	Normal 180 Day Track
S007	2002-07-01	Normal 180 Day Track
S006	2002-06-17	Normal 180 Day Track
S005	2000-07-26	Normal 180 Day Track
S004	2000-03-09	Real-time Process
S003	1999-05-20	Normal 180 Day Track
S002	1999-01-26	Normal 180 Day Track
S001	1998-01-05	Normal 180 Day Track

NIH GUDID Devices

Device ID	PMA	Supp
07630031700100	P930021	013
07630031700025	P930021	013
07630031700087	P930021	013
07630031730046	P930021	020
07630031729989	P930021	020
07630031730015	P930021	020
07630031730022	P930021	020
07630031730039	P930021	020
07630031747389	P930021	024
07630031747372	P930021	024